Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C, Chronic 1 Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 1268 Specimen Handling 871 Carboplatin 831 Magnetic Resonance Spectroscopy 805 Cyclophosphamide 802 Cisplatin 728 Nivolumab 658 Paclitaxel 630 Radiotherapy 573 Gemcitabine 571 Biopsy 529 Bevacizumab 476 Dexamethasone 440 fludarabine 406 Docetaxel 378 venetoclax 370 Oxaliplatin 365 Capecitabine 358 Fluorouracil 355 atezolizumab 344 durvalumab 333 Rituximab 332 Doxorubicin 317 Radiosurgery 309 Pemetrexed 306 Drug Therapy 302 Ipilimumab 294 Standard of Care 293 Etoposide 284 Radiation 281

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × daclatasvir × 1 year × Clear all

NCT02771405 2026-04-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡